Other Transaction Agreement HQ08452390034
Award Date
5/2/23
Potential Completion Date
12/15/24
Potential Value
$11M
Funding Federal Agency
Joint PEO Chemical and Biological Defense
Contracting Federal Agency
Office of the Secretary of Defense
Awardee
Lumen Bioscience, Inc.
Ultimate Awardee
Not listed
NAICS Category
Not listed
PSC Category
AC33 - National Defense R&D Services; Defense-Related Activities; Experimental Development
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed
Major Defense Program
Not listed
Pricing Type
Other
Place of Performance
Seattle, WA 98103, USA
Solicitation Procedures
Program Solicitation
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Lumen Bioscience Inc. was awarded a $703,000 firm fixed price definitive contract by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to deliver its intranasal antibody cocktail delivery platform under Area of Interest 6 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002. This contract supports the agency's goal of mitigating long-term effects of respiratory distress as outlined in Special Instructions 019, which sought...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Lumen Technologies Government Solutions, Inc. (doing business as CenturyLink QGS). The $7,774.50 firm fixed-price purchase order does not utilize a small business set-aside. The contract provides telecommunications, cloud, cybersecurity, and IT services to support NIAID, which conducts research to understand, treat, and...
This is a federal contract award to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.), a technology-focused biomanufacturing company, for a Clinical Development Phase 2 Study. The contract is valued at $107,935,344.00 and has an ultimate completion date of February 29, 2028. The contract was awarded on January 4, 2022 by the Joint Program Executive Office for Chemical and Biological Defense, a component of the U.S. Department of the Army. No set-aside designation was...
This is a federal contract award to Luminex Corp, a foreign-owned, for-profit manufacturer of biological testing technologies, for the delivery of 75 panels for respiratory pathogen testing. The contract has a ceiling value of $331,556.25 and is a Blanket Purchase Agreement (BPA) call with a firm fixed price. The funding agency is the Air Force Life Cycle Management Center (AFLCMC) at Wright-Patterson Air Force Base, which is a defense agency. The contract does not have a small business...
This federal contract award, identified as W911QY2190008, was granted by the Department of the Army's Joint PEO Chemical and Biological Defense to the prime contractor Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The $62,096,250.00 contract, which has no set-aside designation, is for the development of a "COVID-19" Monoclonal Antibody (MAB) Sponsorship Prototype. The contract is an Other Transaction Agreement with a period of performance through...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $5,107,357.36 Other Transaction Agreement to Resilience Government Services, Inc., doing business as Nanotherapeutics Inc., a technology-focused biomanufacturing company. The contract, which has no set-aside designation, is for the development of a "Plasmid Platform Protype" and is part of a larger $5.7 million Indefinite Delivery Vehicle aimed at transferring capabilities to...
This is a $190,241,861.21 Other Transaction Agreement (OTA) awarded by the Joint Program Executive Office for Chemical and Biological Defense, a part of the U.S. Army, to Resilience Government Services, Inc. (doing business as Nanotherapeutics Inc.). The contract is for the provision of goods and services related to chemical and biological defense programs, medical countermeasure development, and pharmaceutical manufacturing. Resilience has previously conducted work for the Department of Defense...
This is a delivery order contract awarded to Luminex Corp, a foreign-owned, for-profit manufacturer of diagnostic technologies, by the Defense agency's Medical Supply Chain. The contract is for $3,685.00 and has a period of performance through February 10, 2025. It is a firm fixed-price contract for the provision of LUMINEX 100/200 Performance Verification products and services. This contract was awarded without any small business set-aside designation. Luminex Corp has also been awarded other...
The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $13,424,714.14 Other Transaction Agreement (OTA) to Sunflower Therapeutics PBC, a woman-owned small business, for the development of a Biologics on Demand Platform Prototype. The contract, which does not have a set-aside designation, was awarded on August 6, 2019, with a completion date of July 15, 2022. This OTA is part of the Department of the Army's efforts to advance chemical and...
This federal contract award is an Other Transaction Agreement between Global Life Sciences Solutions USA LLC and the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency. The $72,104,359.91 cost-sharing agreement is focused on expanding capacity for COVID-19 response and supporting public health emergencies, with a completion date of December 31, 2038. Global Life Sciences Solutions USA LLC, a for-profit limited liability company and wholly owned subsidiary...